Brown Syndrome

National Organization for Rare Disorders, Inc.

Skip to the navigation


It is possible that the main title of the report Brown Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.


  • Superior Oblique Tendon Sheath Syndrome
  • Tendon Sheath Adherence, Superior Oblique

Disorder Subdivisions

  • None

General Discussion

Brown Syndrome is a rare eye disorder characterized by defects in eye movements. This disorder may be present at birth (congenital) or may occur as the result of another underlying disorder (acquired). Muscles control the movements of the eyes. Some of these muscles turn the eyeball up and down, move the eyeball from side to side, or enable the eyeball to rotate slightly in its socket. The superior oblique tendon sheath of the superior oblique muscle surrounds the eyeball. The symptoms of Brown Syndrome are caused by abnormalities of this tendon sheath including shortening, thickening, or inflammation. This results in the inability to move the affected eye upward.


People with Brown Syndrome have limited eye movement in the affected eye. The ability to move the eyeball toward the center (adduction), or outward from the center (abduction), may be restricted or absent. One eye may appear to be out of alignment with the unaffected eye, especially when looking upward. The symptoms of Brown Syndrome may also include a droopy eyelid (ptosis), widening of the eye (palpebral fissure) when looking upward, crossing of the eyes (strabismus), and/or a backward head tilt. A downward appearance (hypotropia) is usually present in the affected eye when the individual is looking straight ahead (primary position) or in an upward direction. One eye is usually affected, but both eyes (bilateral) may be affected in approximately 10 percent of people with Brown Syndrome.


The exact cause of most cases of Congenital Brown Syndrome is not known. The symptoms of congenital Brown Syndrome may occur due to shortening of the tendon sheath of the superior oblique muscle or thickening of the sheath that restricts its movement. However, acquired Brown Syndrome may be the result of trauma, surgery, and/or inflammation due to another underlying disorder such as Lupus or Rheumatoid Arthritis.

There are several reports in the medical literature of a few rare cases of Brown Syndrome which may be inherited as an autosomal dominant genetic trait. Human traits, including the classic genetic diseases, are the product of the interaction of two genes, one received from the father and one from the mother. In dominant disorders, a single copy of the disease gene (received from either the mother or father) will be expressed "dominating" the other normal gene and resulting in the appearance of the disease. The risk of transmitting the disorder from affected parent to offspring is 50 percent for each pregnancy regardless of the sex of the resulting child.

Affected Populations

Brown Syndrome is a rare eye disorder that affects slightly more females than males. The symptoms of the congenital form of the disease are usually present at birth. The acquired form may occur at any age.

Standard Therapies

Some people with congenital Brown Syndrome may not require treatment. Alignment of the eyes may improve with age, especially in those children whose eyes are normally aligned when looking straight ahead. Other individuals with Brown Syndrome may require surgery to correct the alignment of the eyes. During surgery part of the tendon which connects the superior oblique muscle may be removed (sheathectomy with inferior oblique tuck). The results of surgery are usually excellent, but the condition may recur.

If Brown Syndrome is acquired because of another inflammatory disorder such as Lupus or Rheumatoid Arthritis, treatment of the underlying disorder may help to resolve the symptoms of Brown Syndrome.

Investigational Therapies

Information on current clinical trials is posted on the Internet at All studies receiving U.S. government funding, and some supported by private industry, are posted on this government website.

For information about clinical trials being conducted at the National Institutes of Health (NIH) in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222

TTY: (866) 411-1010


For information about clinical trials sponsored by private sources, contact:



Kanski JJ. Ed. Clinical Ophthalmology. 4th ed. Butterworth-Heinemann. Oxford, UK; 1999:543-45.

Behrman RE, Kliegman RM, Arvin AM. Eds. Nelson Textbook of Pediatrics. 15th ed. W.B. Saunder Company. Philadelphia, PA; 1996:1775.


Iannaccone A, McIntosh N, Ciccarelli ML, et al. Familial unilateral Brown syndrome. Ophthalmic Genet. 2002;23:175-84.

Stolovitch C, Leibovitch L, Lowenstein A. Long-term results of superior oblique tendon elongation for Brown syndrome. J Pediatr Ophthalmol Strabismus. 2002;39:90-93.

Maggi R, Maggi C. Tendon surgery in Brown Syndrome. J Pediatr Ophthalmol Strabismus. 2002;39:33-38.

Capasso L, Torre A, Gagliardi V, et al. Spontaneous resolution of congenital Brown syndrome. Ophthalmologica. 2001;215:372-75.

Pandey PK, Chaudhuri Z, Bhatia A. Extraocular muscle cysticercosis presenting as Brown syndrome. Am J Ophthalmol. 2001;131:526-27.

Wright KW. Results of the superior oblique tendon elongation procedure for severe Brown syndrome. Trans Amer Ophthalmol Soc. 2000;98:41-48; discussion 48-50.

Lauer SA. Sauer H, Pak SM. Brown syndrome diagnosed following repair of an orbital roof fracture: a case report. J Craniomaxillofac Trauma. 1998;4:20-22.


Wright K, Salvador MG, Brown Syndrome. eMedicine. Last Updated: April 23, 2001. 14pp.

Strabismus Syndromes. Brown Syndrome. 1999:3pp.

Brown Syndrome. nd. 1p.

Brown Syndrome. nd. 2pp.

Kaiser P, ed. Digital Journal of Ophthalmology. nd. 2pp.


NIH/National Eye Institute

31 Center Dr

MSC 2510

Bethesda, MD 20892-2510

United States

Tel: (301)496-5248

Fax: (301)402-1065



Genetic and Rare Diseases (GARD) Information Center

PO Box 8126

Gaithersburg, MD 20898-8126

Tel: (301)251-4925

Fax: (301)251-4911

Tel: (888)205-2311

TDD: (888)205-3223


For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see